P. Miralles

发表

Hepatitis C virus infection is associated with endothelial dysfunction in HIV/hepatitis C virus coinfected patients

M. Muñoz-Fernández, M. Muñoz-Fernandez, J. Cosín, 2010, AIDS.

Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of HIV type 1 infection: final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903.

E. Ribera, J. Pérez-Molina, Jesús Santos, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with HIV and Hepatitis C virus.

J. Mallolas, C. Quereda, F. Pulido, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clonal Complexity in Mycobacterium tuberculosis Can Hamper Diagnostic Procedures

E. Bouza, M. Herránz, M. J. Ruíz Serrano, 2017, Journal of Clinical Microbiology.

Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma.

A. López-Guillermo, J. Ribera, J. Navarro, 2007, Haematologica.

Characteristics and Outcome of AIDS-Related Hodgkin Lymphoma Before and After the Introduction of Highly Active Antiretroviral Therapy

J. Ribera, J. Torre-Cisneros, R. Palacios, 2008, Journal of acquired immune deficiency syndromes.

HIV-infection impact on clinical–biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy era

A. López-Guillermo, E. González-Barca, J. Sancho, 2015, AIDS.

Bacterial DNA Translocation and Liver Disease Severity Among HIV-Infected Patients With Chronic Hepatitis C

J. Cosín, E. Álvarez, D. Micheloud, 2012, Journal of acquired immune deficiency syndromes.

Effect of Eradication of HCV on Hepatic Venous Pressure Gradient in HIV-Infected Patients With Compensated HCV-Related Cirrhosis.

R. Bañares, J. Berenguer, L. Pérez-Latorre, 2015, Journal of acquired immune deficiency syndromes.

Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus

J. Macías, J. Pineda, A. Rivero, 2009, Hepatology.

Insulin Resistance Impairs Response to Interferon Plus Ribavirin in Patients Coinfected With HIV and Hepatitis C Virus

J. Cosín, P. Catalán, P. Ryan, 2010, Journal of acquired immune deficiency syndromes.

Autologous stem cell transplantation for lymphoma in HIV+ patients: higher rate of infections compared with non-HIV lymphoma

J. Anguita, J. Berenguer, J. Díez-Martín, 2020, Bone Marrow Transplantation.

CD81 expression in peripheral blood lymphocytes before and after treatment with interferon and ribavirin in HIV/HCV coinfected patients

M. Muñoz-Fernandez, J. Cosín, P. Catalán, 2010, HIV medicine.

Hematopoietic Stem Cell Transplantation in Patients Infected With HIV

J. Berenguer, J. Díez-Martín, P. Miralles, 2010, Current HIV/AIDS reports.

Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus‐associated diffuse large B‐cell lymphoma: results of a phase II trial

A. López-Guillermo, E. González-Barca, A. Oriol, 2008, British journal of haematology.

Delayed diagnosis of tuberculosis in persons living with HIV in Eastern Europe: associated factors and effect on mortality—a multicentre prospective cohort study

A. Mocroft, O. Kirk, J. González, 2021, BMC Infectious Diseases.

Treatment of AIDS‐associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy

E. Bouza, J. Cosín, J. Berenguer, 1998, AIDS.

Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus–coinfected patients

J. Macías, J. Pineda, A. Rivero, 2012, Hepatology.

The eldest of older adults living with HIV: response and adherence to highly active antiretroviral therapy.

J. Cosín, J. Berenguer, M. Sánchez-Conde, 2008, The American journal of medicine.

Sustained virologic response decreases serum markers of angiogenesis, inflammation, and fibrosis in HIV/HCV-coinfected patients on hepatitis C virus therapy.

J. Cosín, P. Catalán, D. Micheloud, 2011, AIDS patient care and STDs.

Effects of Hepatitis C Virus (HCV) Eradication on Bone Mineral Density in Human Immunodeficiency Virus/HCV-Coinfected Patients

M. Salavert, J. Navarro, A. Curran, 2020, Clinical Infectious Diseases.

Serum levels of adipokines in HIV/HCV co-infected patients and their association with insulin resistance and liver disease severity.

J. Cosín, E. Álvarez, D. Micheloud, 2010, The Journal of infection.

Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus.

J. Mallolas, M. Crespo, C. Quereda, 2011, The Journal of antimicrobial chemotherapy.

Limited prognostic value of the International Prognostic Score in advanced stage human immunodeficiency virus infection-related Hodgkin lymphoma treated with the doxorubicin, bleomycin, vinblastine, and dacarbazine regimen

A. López-Guillermo, J. Ribera, J. Navarro, 2009, Leukemia & lymphoma.

Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy.

J. Cosín, C. Lacruz, J. Berenguer, 2001, AIDS.

Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase.

J. Cosín, E. Álvarez, J. Berenguer, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Group A Streptococcal Bacteremia: A 10‐Year Prospective Study

E. Bouza, E. Cercenado, P. Catalán, 1997, Medicine.

Association between exposure to nevirapine and reduced liver fibrosis progression in patients with HIV and hepatitis C virus coinfection.

J. Cosín, E. Álvarez, S. Resino, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Soluble Fas and Fas ligand in HIV/HCV coinfected patients and impact of HCV therapy

I. Fernandez de Castro, J. Cosín, P. Catalán, 2011, European Journal of Clinical Microbiology & Infectious Diseases.

High plasma CXCL10 levels are associated with HCV-genotype 1, and higher insulin resistance, fibrosis, and HIV viral load in HIV/HCV coinfected patients.

J. Cosín, P. Catalán, D. Micheloud, 2012, Cytokine.

Diagnostic accuracy of the APRI, FIB-4, and the Forns index for predicting liver fibrosis in HIV/HCV-coinfected patients: a validation study.

J. Cosín, E. Álvarez, S. Resino, 2011, The Journal of infection.

Prospective study on the practice of central nervous system prophylaxis and treatment in non-Hodgkin's lymphoma in Spain.

J. Sancho, J. Ribera, L. Vazquez, 2008, Medicina clinica.

JC virus load in progressive multifocal leukoencephalopathy: analysis of the correlation between the viral burden in cerebrospinal fluid, patient survival, and the volume of neurological lesions.

E. Bouza, M. Marín, J. Berenguer, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Treatment with nandrolone decanoate and megestrol acetate in HIV-infected men.

M. Camblor, I. Bretón, P. Miralles, 2005, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

Plasma IL-6 and IL-9 predict the failure of interferon-α plus ribavirin therapy in HIV/HCV-coinfected patients.

M. Muñoz-Fernández, J. Cosín, D. Micheloud, 2012, The Journal of antimicrobial chemotherapy.

Sustained virological response to interferon-α plus ribavirin decreases inflammation and endothelial dysfunction markers in HIV/HCV co-infected patients.

M. Muñoz-Fernández, J. Cosín, D. Micheloud, 2011, The Journal of antimicrobial chemotherapy.

Prognostic value of liver stiffness in HIV/HCV-Coinfected patients with decompensated cirrhosis

R. Bañares, J. Bellón, J. Berenguer, 2018, BMC Infectious Diseases.

Plasma interferon-gamma-inducible protein-10 can predict virologic response to hepatitis C virus therapy in HIV/HCV-coinfected patients with HCV genotype 1.

J. Cosín, P. Catalán, P. Ryan, 2010, Journal of acquired immune deficiency syndromes.

Cytarabine therapy for progressive multifocal leukoencephalopathy in patients with AIDS.

E. Bouza, M. Díaz, J. B. D. Bernaldo de Quirós, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Dual Qualitative-Quantitative Nested PCR for Detection of JC Virus in Cerebrospinal Fluid: High Potential for Evaluation and Monitoring of Progressive Multifocal Leukoencephalopathy in AIDS Patients Receiving Highly Active Antiretroviral Therapy

E. Bouza, M. Rodríguez-Créixems, R. Alonso, 1999, Journal of Clinical Microbiology.

Lopinavir/Ritonavir as Single-Drug Therapy for Maintenance of HIV-1 Viral Suppression: 48-Week Results of a Randomized, Controlled, Open-Label, Proof-of-Concept Pilot Clinical Trial (OK Study)

A. Carcas, F. Gayá, J. Arribas, 2005, Journal of acquired immune deficiency syndromes.

Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long-term effect on development of tuberculosis and survival.

J. Alberdi, M. Díaz, J. Berenguer, 1997, Archives of internal medicine.

Allogeneic stem cell transplantation in HIV-1 infected patients with high-risk hematological disorders.

J. Anguita, J. Sanz, J. Díez-Martín, 2019, AIDS.

Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study.

J. J. de la Cruz, V. Soriano, M. Vogel, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

An artificial neural network improves the non-invasive diagnosis of significant fibrosis in HIV/HCV coinfected patients.

Fernando Martin-Sanchez, J. Seoane, F. Martín-Sánchez, 2011, The Journal of infection.

Can serum hyaluronic acid replace simple non-invasive indexes to predict liver fibrosis in HIV/Hepatitis C coinfected patients?

M. Muñoz-Fernández, J. Cosín, P. Catalán, 2010, BMC infectious diseases.

Diagnosis of advanced fibrosis in HIV and hepatitis C virus‐coinfected patients via a new noninvasive index: the HGM‐3 index

M. Muñoz-Fernandez, J. Cosín, P. Catalán, 2010, HIV medicine.

Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

D. Podzamczer, J. Mallolas, J. Caylà, 2016, Enfermedades infecciosas y microbiologia clinica.

Nonsurgical cure of isolated cerebral mucormycosis in an intravenous drug user

E. Bouza, J. Cosín, C. Lacruz, 1996, European Journal of Clinical Microbiology and Infectious Diseases.

Graft-versus-tumor effect after allogeneic stem cell transplantation in HIV-positive patients with high-risk hematologic malignancies.

I. Buño, J. Anguita, J. Berenguer, 2013, AIDS research and human retroviruses.

Fever of uncertain origin in patients infected with the human immunodeficiency virus.

E. Bouza, M. Díaz, J. Cosín, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

D. Podzamczer, J. Mallolas, J. Caylà, 2016, Enfermedades infecciosas y microbiologia clinica.

Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus‐coinfected patients and correlation with noninvasive serum markers

J. Cosín, J. Arribas, J. Cosín, 2010, Journal of viral hepatitis.

[GESIDA/PETHEMA guidelines for the diagnosis and treatment of lymphomas in HIV-infected patients].

Jesús Santos, J. Berenguer, J. Díez-Martín, 2002, Medicina clinica.

Pegylated interferon a 2 a plus ribavirin versus pegylated interferon a 2 b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients

C. Tural, J. Mallolas, C. Quereda, 2009 .

Insulin Resistance Is Associated With Advanced Liver Fibrosis and High Body Mass Index in HIV/HCV-Coinfected Patients

P. Catalán, P. Ryan, E. Álvarez, 2009, Journal of acquired immune deficiency syndromes.

Pegylated interferon {alpha}2a plus ribavirin versus pegylated interferon {alpha}2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients.

C. Tural, J. Mallolas, C. Quereda, 2009, The Journal of antimicrobial chemotherapy.

Pegylated interferon a 2a plus ribavirin versus pegylated interferon a 2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients

C. Tural, J. Mallolas, C. Quereda, 2009 .

Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression

D. Podzamczer, B. Clotet, J. Arribas, 2009, Antiviral therapy.

Differential characteristics of HIV-infected penitentiary patients and HIV-infected community patients

E. Bouza, J. Pérez-Molina, C. González, 2002, HIV clinical trials.

Prediction of Hepatic Fibrosis in Patients Coinfected With HIV and Hepatitis C Virus Based on Genetic Markers

E. Álvarez, D. Micheloud, S. Resino, 2013, Journal of acquired immune deficiency syndromes.

IL28B polymorphisms are associated with severity of liver disease in human immunodeficiency virus (HIV) patients coinfected with hepatitis C virus.

J. Cosín, P. Catalán, E. Álvarez, 2013, The Journal of infection.

Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)

B. Clotet, M. Odriozola, J. Olalla, 2017, The Journal of antimicrobial chemotherapy.

Prognosis of AIDS-Related Systemic Non-Hodgkin Lymphoma Treated With Chemotherapy and Highly Active Antiretroviral Therapy Depends Exclusively on Tumor-Related Factors

J. Ribera, Jesús Santos, J. Berenguer, 2007, Journal of acquired immune deficiency syndromes.

Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain

G. Marcaida, J. Niubó, V. Cuervas-Mons, 2019, The Journal of antimicrobial chemotherapy.

GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus.

J. Menárguez, S. Villà, J. Navarro, 2018, Medicina clinica.

HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation.

I. Buño, J. Ribera, J. Berenguer, 2005, Experimental hematology.

Long‐term follow‐up of patients with HIV‐related diffuse large B‐cell lymphomas treated in a phase II study with rituximab and CHOP

A. López-Guillermo, E. González-Barca, J. Ribera, 2012, British journal of haematology.

Long-term follow up of patients with human immunodeficiency virus infection and advanced stage Hodgkin's lymphoma treated with doxorubicin, bleomycin, vinblastine and dacarbazine

J. Ribera, P. Miralles, M. Morgades, 2013, Haematologica.

Risk for Developing Tuberculosis among Anergic Patients Infected with HIV

J. Alberdi, E. Bouza, T. Vicente, 1993, Annals of Internal Medicine.

Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis

C. Marra, A. Antinori, P. Cinque, 2008, AIDS.

IL28RA polymorphism (rs10903035) is associated with insulin resistance in HIV/HCV‐coinfected patients

D. Micheloud, S. Resino, M. Jiménez-Sousa, 2014, Journal of viral hepatitis.

Mechanisms That Contribute to a Profound Reduction of the HIV-1 Reservoir After Allogeneic Stem Cell Transplant

B. Clotet, J. Martinez-Picado, A. Wensing, 2018, Annals of Internal Medicine.

Association of torque teno virus (TTV) and torque teno mini virus (TTMV) with liver disease among patients coinfected with human immunodeficiency virus and hepatitis C virus

M. Muñoz-Fernandez, J. Cosín, E. Álvarez, 2012, European Journal of Clinical Microbiology & Infectious Diseases.

Impact of HIV on the health-related quality of life in youth with perinatally acquired HIV

P. Rojo, P. Miralles, J. Ramos, 2019, World Journal of Pediatrics.

Negative influence of age on CD4+ cell recovery after highly active antiretroviral therapy in naive HIV-1-infected patients with severe immunodeficiency.

M. Muñoz-Fernández, J. Cosín, D. Micheloud, 2008, The Journal of infection.

Prediction of liver complications in patients with hepatitis C virus-related cirrhosis with and without HIV coinfection: comparison of hepatic venous pressure gradient and transient elastography.

R. Bañares, J. Bellón, J. Berenguer, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Identification of liver fibrosis in HIV/HCV‐coinfected patients using a simple predictive model based on routine laboratory data

F. Álvarez, J. Cosín, P. Catalán, 2007, Journal of viral hepatitis.

Genetic variation in CCR2 and CXCL12 genes impacts on CD4 restoration in patients initiating cART with advanced immunesupression

J. Benito, J. Blanco, Y. Pacheco, 2019, PloS one.

Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR

I. Martínez, M. Salavert, E. Ribera, 2019, Scientific Reports.

Outcome of HCV/HIV‐Coinfected Liver Transplant Recipients: A Prospective and Multicenter Cohort Study

E. Cordero, A. Rimola, J. Torre-Cisneros, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

IL28RA polymorphism is associated with early hepatitis C virus (HCV) treatment failure in human immunodeficiency virus‐/HCV‐coinfected patients

V. Soriano, J. Cosín, N. Rallón, 2013, Journal of viral hepatitis.

PPARγ2 Pro12Ala polymorphism was associated with favorable cardiometabolic risk profile in HIV/HCV coinfected patients: a cross-sectional study

D. Micheloud, S. Resino, M. Jiménez-Sousa, 2014, Journal of Translational Medicine.

HTLV testing of solid organ transplant donors

J. Miro, E. Poveda, S. Sauleda, 2019, Clinical transplantation.

Using the Lymph2Cx assay for assessing cell-of-origin subtypes of HIV-related diffuse large B-cell lymphoma

J. Briones, J. Gribben, S. Montoto, 2018, Leukemia & lymphoma.

TLR3 polymorphisms are associated with virologic response to hepatitis C virus (HCV) treatment in HIV/HCV coinfected patients.

J. Benito, V. Soriano, J. Cosín, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Dose‐intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status

J. Esteve, M. Tormo, J. Hernández-Rivas, 2013, Cancer.

Long-term (4 years) efficacy of lopinavir/ritonavir monotherapy for maintenance of HIV suppression.

J. Arribas, R. Delgado, F. Pulido, 2008, The Journal of antimicrobial chemotherapy.

Comparison of CHOP treatment with specific short-intensive chemotherapy in AIDS-related Burkitt's lymphoma or leukemia.

J. Esteve, A. Oriol, S. Brunet, 2011, Medicina clinica.

HLA-E variants are associated with sustained virological response in HIV/hepatitis C virus-coinfected patients on hepatitis C virus therapy

J. Benito, V. Soriano, J. Cosín, 2013, AIDS.

Clinical Presentation of Individuals With Human T-Cell Leukemia Virus Type-1 Infection in Spain

J. Miro, E. Poveda, S. Sauleda, 2019, Open forum infectious diseases.

Discontinuation of secondary anti-leishmania prophylaxis in HIV-infected patients who have responded to highly active antiretroviral therapy.

J. Cosín, J. Berenguer, B. Padilla, 2000, AIDS.

European mitochondrial haplogroups predict liver-related outcomes in patients coinfected with HIV and HCV: a retrospective study

S. Resino, J. Bellón, M. Jiménez-Sousa, 2019, Journal of Translational Medicine.

Soluble Adhesion Molecules in Patients Coinfected with HIV and HCV: A Predictor of Outcome

S. Resino, J. Bellón, M. Jiménez-Sousa, 2016, PloS one.

European mitochondrial DNA haplogroups and liver fibrosis in HIV and hepatitis C virus coinfected patients

J. Cosín, E. Álvarez, D. Micheloud, 2011, AIDS.

Impact of inosine triphosphatase gene variants on the risk of anemia in HIV/hepatitis C virus-coinfected patients treated for chronic hepatitis C.

J. Benito, V. Soriano, J. Pineda, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy.

J. Mallolas, E. Ribera, M. Márquez, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Bacterial translocation and clinical progression of HCV‐related cirrhosis in HIV‐infected patients

J. Macías, S. Resino, M. Jiménez-Sousa, 2018, Journal of viral hepatitis.

Frailty and physical function in older HIV-infected adults

S. Moreno, M. Pérez-Elías, A. Moreno, 2017, Age and ageing.

Lipid disorders in antiretroviral-naive patients treated with lopinavir/ritonavir-based HAART: frequency, characterization and risk factors.

J. Arribas, J. Peña, E. Navas, 2005, The Journal of antimicrobial chemotherapy.

Tuberculin reaction size in patients infected with HIV.

J. Cosín, J. Berenguer, S. Moreno, 1995, AIDS.

Liver Retransplantation in HIV‐Infected Patients: A Prospective Cohort Study

E. Cordero, M. Mata, A. Rimola, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

European mitochondrial haplogroups predict liver-related outcomes in patients coinfected with HIV and HCV: a retrospective study

S. Resino, J. Bellón, M. Jiménez-Sousa, 2019, Journal of Translational Medicine.

Association between plasma levels of eotaxin (CCL-11) and treatment response to interferon-alpha and ribavirin in HIV/HCV co-infected patients.

J. Cosín, P. Catalán, S. Resino, 2010, The Journal of antimicrobial chemotherapy.

European Mitochondrial DNA Haplogroups and Metabolic Disorders in HIV/HCV-Coinfected Patients on Highly Active Antiretroviral Therapy

J. Cosín, P. Catalán, D. Micheloud, 2011, Journal of acquired immune deficiency syndromes.

PPAR&ggr;2 Pro12Ala Polymorphism Is Associated With Sustained Virological Response in HIV/HCV-Coinfected Patients Under HCV Therapy

V. Soriano, J. Cosín, N. Rallón, 2014, Journal of acquired immune deficiency syndromes.

Comparison of high ribavirin induction versus standard ribavirin dosing, plus peginterferon-α for the treatment of chronic hepatitis C in HIV-infected patients: the PERICO trial.

V. Soriano, J. Pineda, A. Terrón, 2012, The Journal of infectious diseases.

Preemptive erythropoietin plus high ribavirin doses to increase rapid virological responses in HIV patients treated for chronic hepatitis C.

V. Soriano, S. Rodríguez-Nóvoa, C. Miralles, 2010, AIDS research and human retroviruses.

Use of transient elastography (FibroScan®) for the noninvasive assessment of portal hypertension in HIV/HCV‐coinfected patients

J. Cosín, C. Ripoll, R. Bañares, 2011, Journal of viral hepatitis.

Association of torque teno virus (TTV) and torque teno mini virus (TTMV) with liver disease among patients coinfected with human immunodeficiency virus and hepatitis C virus

J. Cosín, P. Catalán, E. Álvarez, 2013, European Journal of Clinical Microbiology & Infectious Diseases.

Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial

J. De La Torre, J. Prada, S. Reus, 2018, The Journal of antimicrobial chemotherapy.

Zidovudine treatment prevents vertical transmission of human immunodeficiency virus‐1 independently of viral load

M. Gurbindo, E. Fernandez-cruz, P. Miralles, 1998, Acta paediatrica.

Analysis of IL28B alleles with virologic response patterns and plasma cytokine levels in HIV/HCV-coinfected patients

J. Benito, V. Soriano, J. Cosín, 2013, AIDS.

European mitochondrial haplogroups are not associated with hepatitis C virus (HCV) treatment response in HIV/HCV‐coinfected patients

V. Soriano, N. Rallón, S. Resino, 2014, HIV medicine.

Nelfinavir Plus Nevirapine Plus Two NRTIs As Salvage Therapy for HIV-Infected Patients Receiving Long-Term Antiretroviral Treatment

E. Bouza, J. Cosín, J. Pérez-Molina, 2001, HIV clinical trials.

IL28RA polymorphism is associated with early hepatitis C virus (HCV) treatment failure in human immunodeficiency virus‐/HCV‐coinfected patients

J. Benito, V. Soriano, J. Cosín, 2013, Journal of viral hepatitis.

Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with HIV and Hepatitis C virus.

J. Mallolas, C. Quereda, F. Pulido, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.